{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T21:57:16Z","timestamp":1791496636813,"version":"4.3.4"},"reference-count":13,"publisher":"Georg Thieme Verlag KG","issue":"02","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropediatrics"],"published-print":{"date-parts":[[2021,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Sleep-related hypermotor epilepsy (SHE) is a rare syndrome that presents with hyperkinetic asymmetric tonic\/dystonic seizures with vegetative signs, vocalization, and emotional facial expression, mainly during light non-rapid eye movement sleep stages. The role of various genes (CHRNA4, CHRNB2, CHRNA2, KCNT1, DEPDC5, NPRL2, NPRL3, and PRIMA1) has previously been reported, though genetic etiology is assessed in less than 10% of cases. We report the case of a 5-year-old female carrying the TSC1 variant c.843del p.(Ser282Glnfs*36) who presented with a mild phenotype of tuberous sclerosis, including carbamazepine-responsive SHE, normal neurocognitive functioning, hypomelanotic macules, no abnormalities outside the central nervous system, and tubers at neuroimaging. The presented case extends the list of SHE-related genes to include TSC1, thus suggesting a central pathogenic role of mammalian target of rapamycin (mTOR) cascade dysfunction in SHE and introducing a possible use of mTOR inhibitors in this epileptic syndrome.<\/jats:p>","DOI":"10.1055\/s-0041-1722881","type":"journal-article","created":{"date-parts":[[2021,2,14]],"date-time":"2021-02-14T05:14:01Z","timestamp":1613279641000},"page":"146-149","source":"Crossref","is-referenced-by-count":7,"title":["TSC1 as a Novel Gene for Sleep-Related Hypermotor Epilepsy: A Child with a Mild Phenotype of Tuberous Sclerosis"],"prefix":"10.1055","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7664-5807","authenticated-orcid":false,"given":"Mario","family":"Mastrangelo","sequence":"additional","affiliation":[{"name":"Child Neurology and Infantile Psychiatry Unit, Department of Human Neuroscience, Sapienza University of Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Commone","sequence":"additional","affiliation":[{"name":"Child Neurology and Infantile Psychiatry Unit, Department of Human Neuroscience, Sapienza University of Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Greco","sequence":"additional","affiliation":[{"name":"Child Neurology and Infantile Psychiatry Unit, Department of Human Neuroscience, Sapienza University of Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Leuzzi","sequence":"additional","affiliation":[{"name":"Child Neurology and Infantile Psychiatry Unit, Department of Human Neuroscience, Sapienza University of Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2021,2,12]]},"reference":[{"issue":"19","key":"ref1","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1212\/WNL.0000000000002666","article-title":"Definition and diagnostic criteria of sleep-related hypermotor epilepsy","volume":"86","author":"P Tinuper","year":"2016","journal-title":"Neurology"},{"issue":"08","key":"ref2","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1002\/acn3.224","article-title":"PRIMA1 mutation: a new cause of nocturnal frontal lobe epilepsy","volume":"2","author":"M S Hildebrand","year":"2015","journal-title":"Ann Clin Transl Neurol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.seizure.2019.11.009","article-title":"Sleep-related hypermotor epilepsy (SHE): Contribution of known genes in 103 patients","volume":"74","author":"L Licchetta","year":"2020","journal-title":"Seizure"},{"issue":"12","key":"ref4","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1038\/ejhg.2016.85","article-title":"Genotype and brain pathology phenotype in children with tuberous sclerosis complex","volume":"24","author":"I E Overwater","year":"2016","journal-title":"Eur J Hum Genet"},{"issue":"07","key":"ref5","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S1474-4422(15)00069-1","article-title":"Neurological and neuropsychiatric aspects of tuberous sclerosis complex","volume":"14","author":"P Curatolo","year":"2015","journal-title":"Lancet Neurol"},{"issue":"08","key":"ref6","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1136\/jmedgenet-2016-103883","article-title":"GATOR1 complex: the common genetic actor in focal epilepsies","volume":"53","author":"S Baldassari","year":"2016","journal-title":"J Med Genet"},{"issue":"06","key":"ref7","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1111\/epi.13391","article-title":"Involvement of GATOR complex genes in familial focal epilepsies and focal cortical dysplasia","volume":"57","author":"S Weckhuysen","year":"2016","journal-title":"Epilepsia"},{"issue":"23","key":"ref8","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1212\/WNL.0000000000000488","article-title":"DEPDC5 mutations in families presenting as autosomal dominant nocturnal frontal lobe epilepsy","volume":"82","author":"F Picard","year":"2014","journal-title":"Neurology"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.3389\/fnins.2019.01089","article-title":"Carbamazepine alleviates retinal and optic nerve neural degeneration in diabetic mice via nerve growth factor-induced PI3K\/Akt\/mTOR activation","volume":"13","author":"N M Elsherbiny","year":"2019","journal-title":"Front Neurosci"},{"issue":"05","key":"ref10","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.ejpn.2018.05.006","article-title":"Management of epilepsy associated with tuberous sclerosis complex: updated clinical recommendations","volume":"22","author":"P Curatolo","year":"2018","journal-title":"Eur J Paediatr Neurol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/brain\/awl322","article-title":"Surgical treatment of drug-resistant nocturnal frontal lobe epilepsy","volume":"130","author":"L Nobili","year":"2007","journal-title":"Brain"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1016\/S0140-6736(16)31419-2","article-title":"Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled study","volume":"388","author":"J A French","year":"2016","journal-title":"Lancet"},{"issue":"07","key":"ref13","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S2352-4642(18)30099-3","article-title":"Adjunctive everolimus for children and adolescents with treatment-refractory seizures associated with tuberous sclerosis complex: post-hoc analysis of the phase 3 EXIST-3 trial","volume":"2","author":"P Curatolo","year":"2018","journal-title":"Lancet Child Adolesc Health"}],"container-title":["Neuropediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0041-1722881.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,20]],"date-time":"2021-03-20T00:28:57Z","timestamp":1616200137000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0041-1722881"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,12]]},"references-count":13,"journal-issue":{"issue":"02","published-online":{"date-parts":[[2021,3,19]]},"published-print":{"date-parts":[[2021,4]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0041-1722881","relation":{},"ISSN":["0174-304X","1439-1899"],"issn-type":[{"value":"0174-304X","type":"print"},{"value":"1439-1899","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,12]]}}}